All Stories

  1. Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patients

    Article • Expert Review of Gastroenterology & Hepatology, September 2018, Taylor & Francis

    Tian Yang, Jian-Hong Zhong

  2. Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance

    Article • Journal of Viral Hepatitis, May 2018, Wiley

    Jian-Hong Zhong

  3. Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance

    Article • Alimentary Pharmacology & Therapeutics, October 2017, Wiley

    Jian-Hong Zhong

  4. Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus

    Article • Alimentary Pharmacology & Therapeutics, August 2017, Wiley

    Jian-Hong Zhong

  5. Extrahepatic metastasectomy for hepatocellular carcinoma: Predictors of long-term survival

    Article • Journal of Surgical Oncology, March 2017, Wiley

    Jian-Hong Zhong

  6. Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients

    Article • Journal of Hepatocellular Carcinoma, December 2016, Dove Medical Press

    Jian-Hong Zhong

  7. Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma

    Article • Liver International, November 2016, Wiley

    Jian-Hong Zhong

  8. Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection

    Article • OncoTargets and Therapy, November 2016, Dove Medical Press

    Jian-Hong Zhong

  9. Are another 5 years of adjuvant aromatase inhibitor therapy needed?

    Article • Breast Cancer Targets and Therapy, November 2016, Dove Medical Press

    Jian-Hong Zhong

  10. Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis

    Article • OncoTargets and Therapy, April 2016, Dove Medical Press

    Jian-Hong Zhong

  11. Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma

    Article • Drug Design Development and Therapy, October 2015, Dove Medical Press

    Jian-Hong Zhong

  12. Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma

    Article • Medicine, September 2015, Wolters Kluwer Health

    Jian-Hong Zhong

  13. Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion

    Article • Medicine, January 2015, Wolters Kluwer Health

    Jian-Hong Zhong

  14. Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma

    Article • Hepatology Research, December 2014, Wiley

    Jian-Hong Zhong